Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Conventional Microscopical versus Digital Whole-Slide Imaging-Based Diagnosis of Thin-Layer Cervical Specimens: A Validation Study.

Bongaerts O, Clevers C, Debets M, Paffen D, Senden L, Rijks K, Ruiten L, Sie-Go D, van Diest PJ, Nap M.

J Pathol Inform. 2018 Aug 27;9:29. doi: 10.4103/jpi.jpi_28_18. eCollection 2018.

2.

A phase 1 'window-of-opportunity' trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.

Larue RT, Van De Voorde L, Berbée M, van Elmpt WJ, Dubois LJ, Panth KM, Peeters SG, Claessens A, Schreurs WM, Nap M, Warmerdam FA, Erdkamp FL, Sosef MN, Lambin P.

BMC Cancer. 2016 Aug 17;16:644. doi: 10.1186/s12885-016-2709-z.

3.
4.

Working toward consensus among professionals in the identification of classical cervical cytomorphological characteristics in whole slide images.

Bongaerts O, van Diest PJ, Pieters M, Nap M.

J Pathol Inform. 2015 Sep 28;6:52. doi: 10.4103/2153-3539.166013. eCollection 2015.

5.

Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol.

Noordman BJ, Shapiro J, Spaander MC, Krishnadath KK, van Laarhoven HW, van Berge Henegouwen MI, Nieuwenhuijzen GA, van Hillegersberg R, Sosef MN, Steyerberg EW, Wijnhoven BP, van Lanschot JJ; SANO study group.

JMIR Res Protoc. 2015 Jun 29;4(2):e79. doi: 10.2196/resprot.4320.

6.

Expertise in clinical pathology: combining the visual and cognitive perspective.

Jaarsma T, Jarodzka H, Nap M, van Merriënboer JJ, Boshuizen HP.

Adv Health Sci Educ Theory Pract. 2015 Oct;20(4):1089-106. doi: 10.1007/s10459-015-9589-x. Epub 2015 Feb 13.

7.

Reproducibility studies for experimental epitope detection in macrophages (EDIM).

Japink D, Nap M, Sosef MN, Nelemans PJ, Coy JF, Beets G, von Meyenfeldt MF, Leers MP.

J Immunol Methods. 2014 May;407:40-7. doi: 10.1016/j.jim.2014.03.018. Epub 2014 Mar 28.

PMID:
24685835
8.

Expertise under the microscope: processing histopathological slides.

Jaarsma T, Jarodzka H, Nap M, van Merrienboer JJ, Boshuizen HP.

Med Educ. 2014 Mar;48(3):292-300. doi: 10.1111/medu.12385.

PMID:
24528464
9.

PET/CT-based metabolic tumour volume for response prediction of neoadjuvant chemoradiotherapy in oesophageal carcinoma.

Blom RL, Steenbakkers IR, Lammering G, Vliegen RF, Belgers EJ, de Jonge C, Schreurs WM, Nap M, Sosef MN.

Eur J Nucl Med Mol Imaging. 2013 Oct;40(10):1500-6. doi: 10.1007/s00259-013-2468-x. Epub 2013 Jun 14.

PMID:
23764889
10.

The evaluation of colon biopsies using virtual microscopy is reliable.

van der Post RS, van der Laak JA, Sturm B, Clarijs R, Schaafsma HE, van Krieken JH, Nap M.

Histopathology. 2013 Jul;63(1):114-21. doi: 10.1111/his.12131. Epub 2013 May 21.

PMID:
23692065
11.

Automated colorectal cancer diagnosis for whole-slice histopathology.

Kalkan H, Nap M, Duin RP, Loog M.

Med Image Comput Comput Assist Interv. 2012;15(Pt 3):550-7.

PMID:
23286174
12.

Whole slide images as a platform for initial diagnostics in histopathology in a medium-sized routine laboratory.

Al-Janabi S, Huisman A, Nap M, Clarijs R, van Diest PJ.

J Clin Pathol. 2012 Dec;65(12):1107-11. doi: 10.1136/jclinpath-2012-200878. Epub 2012 Oct 23.

PMID:
23093511
13.

A travel report of the implementation of virtual whole slide images in routine surgical pathology.

Nap M, Teunissen R, Pieters M.

APMIS. 2012 Apr;120(4):290-7. doi: 10.1111/j.1600-0463.2011.02870.x. Review.

PMID:
22429211
14.

Data-driven compensation for flow cytometry of solid tissues.

van Rodijnen NM, Pieters M, Hoop S, Nap M.

Adv Bioinformatics. 2011;2011:184731. doi: 10.1155/2011/184731. Epub 2011 Sep 6.

15.

FDG-PET provides the best correlation with the tumor specimen compared to MRI and CT in rectal cancer.

Buijsen J, van den Bogaard J, Janssen MH, Bakers FC, Engelsman S, Öllers M, Beets-Tan RG, Nap M, Beets GL, Lambin P, Lammering G.

Radiother Oncol. 2011 Feb;98(2):270-6. doi: 10.1016/j.radonc.2010.11.018. Epub 2011 Feb 3.

16.

Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort.

Juillerat P, Pittet V, Mottet C, Felley C, Gonvers JJ, Vader JP, Burnand B, Froehlich F, Wolters FL, Stockbrügger RW, Michetti P; EC-IBD Group.

Scand J Gastroenterol. 2010 Dec;45(12):1449-56. doi: 10.3109/00365521.2010.505660. Epub 2010 Jul 26.

PMID:
20653489
17.

CEA in activated macrophages. New diagnostic possibilities for tumor markers in early colorectal cancer.

Japink D, Leers MP, Sosef MN, Nap M.

Anticancer Res. 2009 Aug;29(8):3245-51.

18.

Why determine only the total prostate-specific antigen, if the free-to-total ratio contains the information?

Eekers DB, Laschet A, de Groot M, Roelofs E, Kester A, Delaere K, Lambin P, van Gils F, Nap M, ten Kate J.

Ann Clin Biochem. 2008 May;45(Pt 3):270-4. doi: 10.1258/acb.2007.007014.

PMID:
18482915
19.

Circulating PSA-containing macrophages as a possible target for the detection of prostate cancer: a three-color/five-parameter flow cytometric study on peripheral blood samples.

Leers MP, Nap M, Herwig R, Delaere K, Nauwelaers F.

Am J Clin Pathol. 2008 Apr;129(4):649-56. doi: 10.1309/THWWRU8L42U5H9PB.

PMID:
18343793
20.

Breast-conserving therapy for palpable and nonpalpable breast cancer: can surgical residents do the job irrespective of experience?

Cleffken B, Postelmans J, Olde Damink S, Nap M, Schreutelkamp I, van der Bijl H.

World J Surg. 2007 Sep;31(9):1731-6.

Supplemental Content

Loading ...
Support Center